This page collects WhisperX intelligence signals tagged #SEC 8-K. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Amicus Therapeutics filed a Form 8-K with the SEC on April 27, 2026, disclosing a cluster of material corporate events that together suggest a significant ownership or strategic transition. The filing incorporates Item 1.02 (termination of a material definitive agreement), Item 2.01 (completion of an acquisition or dis...
United Homes Group, Inc. (CIK: 0001830188) filed an 8-K on May 4, 2026, triggering an unusually broad cluster of material disclosure items that together signal a major corporate restructuring, raising the risk of delisting and a fundamental shift in control of the company. The filing activates nine separate SEC disclo...
Calidi Biotherapeutics, Inc. has triggered multiple disclosure items in a new SEC 8-K filing that points to significant corporate activity. The biotech company reported both the entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, a combination that typ...
Rockwell Medical, Inc. has filed a disclosure with the Securities and Exchange Commission that signals potential trouble maintaining its stock exchange listing. The company submitted an 8-K filing on May 8, 2026, under Item 3.01, a regulatory category specifically reserved for notices of delisting or failure to satisfy...